कृपया अन्य खोज का प्रयास करें
Jiangsu Recbio Technology Co., Ltd., a vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People’s Republic of China. The company is developing vaccines for the treatment of cervical cancer, and anal and genital warts, including REC603, a recombinant human papillomavirus (HPV) 9-valent vaccine that is in phase III clinical trial; REC601 and REC602 recombinant HPV bivalent vaccines, which are in phase I clinical trials; REC604a, a recombinant HPV quadrivalent vaccine that is in pre-clinical stage; and REC604b, a recombinant HPV 9-valent vaccine that is in pre-clinical stage. It also develops ReCOV, a recombinant COVID-19 vaccine candidate that is in Phase II/III trial; R520A, a messenger ribonucleic acid COVID-19 vaccine candidate that is in pre-clinical stage; REC610, a recombinant shingles vaccine that is in Phase l clinical trial; REC607, a virus vectored adult tuberculosis vaccine that is in pre-clinical stage; REC606, a recombinant adult tuberculosis vaccine that is in pre-clinical stage; REC617, a recombinant influenza quadrivalent vaccine that is in pre-clinical stage; and REC605, a recombinant hand-foot-mouth disease quadrivalent vaccine that is in pre-clinical stage. Jiangsu Recbio Technology Co., Ltd. was founded in 2011 and is headquartered in Taizhou, the People’s Republic of China.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Feng Gao | 61 | 2021 | Independent Non-Executive Director |
Hongbin Zhou | 50 | 2020 | Non-Executive Director |
Houwei Hu | - | 2023 | Non-Executive Director |
Weiwei Qiao | 36 | 2021 | Chairman of the Supervisory Board |
Jiaxin Zhang | - | 2023 | Non-Executive Director |
Ming Fai Yuen | 73 | 2021 | Independent Non-Executive Director |
Guodong Liang | 71 | 2021 | Independent Non-Executive Director |
Lijun Xia | 47 | 2021 | Independent Non-Executive Director |
Jianping Chen | 46 | 2019 | Vice GM & Executive Director |
Kunxue Hong | 59 | 2021 | Chief Scientist & Non-Executive Director |
Bu Li | 47 | 2021 | Vice GM & Executive Director |
Qingqing Chen | 41 | 2021 | Vice GM, CFO, Secretary & Executive Director |
Yong Liu | 51 | 2011 | Founder, CEO, GM & Chairman of the Board |
Feizhou Wang | 57 | 2022 | Supervisor |
Ranting Qian | 48 | 2021 | Supervisor |
Ping Liu | 45 | 2022 | Employee Representative Supervisor |
Ruwei Wang | - | 2024 | Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है